A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor

Bacteriophages represent a promising option for the treatment of Clostridioides difficile (formerly Clostridium difficile) infection (CDI), which at present relies on conventional antibiotic therapy. The specificity of bacteriophages should prevent dysbiosis of the colonic microbiota associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Whittle, M. J., Bilverstone, T. W., van Esveld, R. J., Lücke, A. C., Lister, M. M., Kuehne, S. A., Minton, N. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809339/
https://www.ncbi.nlm.nih.gov/pubmed/35107319
http://dx.doi.org/10.1128/spectrum.02295-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809339/
https://www.ncbi.nlm.nih.gov/pubmed/35107319
http://dx.doi.org/10.1128/spectrum.02295-21

Ejemplares similares